Detalhe da pesquisa
1.
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Clin Infect Dis
; 76(3): e1177-e1185, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164254
2.
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.
Mol Ther
; 29(7): 2366-2377, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781913
3.
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.
Clin Infect Dis
; 73(5): 775-782, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580234
4.
Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan1.
Emerg Infect Dis
; 26(3): 427-436, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32091355
5.
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.
J Antimicrob Chemother
; 72(11): 3131-3140, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961737
6.
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.
PLoS Negl Trop Dis
; 18(4): e0012078, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640118
7.
Survey of causative agents for acute respiratory infections among patients in Khartoum-State, Sudan, 2010-2011.
Virol J
; 10: 312, 2013 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24160894
8.
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients.
Clin Pharmacokinet
; 60(11): 1463-1473, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105063
9.
Loss of balancing selection in the betaS globin locus.
BMC Med Genet
; 11: 21, 2010 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20128890
10.
Ovarian Cancer: Tumor-Specific Urinary Micro-Peptides Profiling as Potential Biomarkers for Early Diagnosis.
Proteomes
; 8(4)2020 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33137912
11.
Evaluation of the particle gel diffusion technique for the detection of haemoglobin S in Sudanese patients.
Ann Clin Biochem
; 46(Pt 2): 114-6, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19164340
12.
Surgical treatment of mucocele of the appendix: a systematic review and case report.
J Surg Case Rep
; 2018(6): rjy102, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991998
13.
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.
Front Cell Infect Microbiol
; 8: 181, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29911074
14.
Etiological Trends and Patterns of Antimicrobial Resistance in Respiratory Infections.
Open Microbiol J
; 12: 34-40, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785214
15.
Smear Microscopy for Diagnosis of Pulmonary Tuberculosis in Eastern Sudan.
Tuberc Res Treat
; 2018: 8038137, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30013800
16.
High altitude and pre-eclampsia: Adaptation or protection.
Med Hypotheses
; 104: 128-132, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28673571
17.
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
Clin Drug Investig
; 37(3): 259-272, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066878
18.
The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis.
Trans R Soc Trop Med Hyg
; 110(6): 321-3, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27268714
19.
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
PLoS Negl Trop Dis
; 8(1): e2613, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24454970
20.
The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
Am J Trop Med Hyg
; 89(6): 1146-1153, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189368